Anteris Technologies Global Corp. Common Stock (AVR)
ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
- Headquarters
- United States
- Employees
- 174
- Market Cap
- $814M
About Anteris Technologies Global Corp. Common Stock
Anteris Technologies Global Corp is a structural heart company focused on advancing cardiac care through science-driven innovations aimed at restoring heart valve patients to healthy function. Its key product, the DurAVR Transcatheter Heart Valve (THV), was designed in partnership with interventional cardiologists and cardiac surgeons to treat Aortic Stenosis, a potentially life-threatening condition caused by narrowing of the aortic valve. The balloon-expandable DurAVR THV is a biomimetic valve designed to mimic the performance of a healthy human aortic valve and replicate normal aortic blood flow. The company operates in United States, Germany, Australia, Switzerland, and Sweden, with the majority of its revenue generated from the United States.
SentiSense also tracks daily options readings for Anteris Technologies Global Corp. Common Stock: IV rank, put/call percentile, 25-delta skew, open-interest walls, and unusually active contracts, each measured against the stock's own history. Sign in to view them.
Anteris Technologies Global Corp. Common Stock stock analysis, sentiment tracking, and market intelligence on SentiSense.